Clinical-stage biopharmaceutical company developing autologous and allogeneic cell therapies for cancer and autoimmune diseases
Clinical-stage biopharmaceutical company developing autologous and allogeneic cell therapies for cancer and autoimmune diseases. Its FasTCAR, TruUCAR, and SMART CART platforms aim to improve CAR-T manufacturing speed and T-cell quality and address treatment challenges in solid tumors.